Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Hyuck Shim

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Cell Biology|March 29, 2006
CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesisJae-Hyuck Shim, Changchun Xiao, Matthew S Hayden, et al.
The Journal of Clinical Investigation|August 16, 2013
Schnurri-3 regulates ERK downstream of WNT signaling in osteoblastsJae-Hyuck Shim, Matthew B Greenblatt, Weiguo Zou, et al.
Experimental & Molecular Medicine|November 18, 2025
PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathwaysJi Hye Shin, Ji Young Kim, Mi-Jeong Kim, et al.
Cell Death & Disease|December 19, 2025
USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesisJi Hye Shin, Ji Young Kim, Seo Hyun Kim, et al.
The Journal of Clinical Investigation|June 17, 2010
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in miceMatthew B Greenblatt, Jae-Hyuck Shim, Weiguo Zou, et al.
Nature|September 26, 2018
Discovery of a periosteal stem cell mediating intramembranous bone formationShawon Debnath, Alisha R Yallowitz, Jason McCormick, et al.
Biomarker Research|July 9, 2025
USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibitionJi Hye Shin, Ji Young Kim, Mi-Jeong Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 10, 2013
Amelioration of neurodegenerative diseases by cell death-induced cytoplasmic delivery of humaninTae-Yoon Park, Seung-Hyung Kim, Yoon-Chul Shin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 2025
New Lens On Congenital Mild Bone Fragility: a Novel Col1a1 Knockout Mouse Model for Osteogenesis Imperfecta Type 1Lidiia Zhytnik, Laura Ventura, Anastasia Sclocco, et al.
The Journal of Experimental Medicine|July 22, 2015
CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclastsMatthew B Greenblatt, Kwang Hwan Park, Hwanhee Oh, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Cell Biology|March 29, 2006
CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesisJae-Hyuck Shim, Changchun Xiao, Matthew S Hayden, et al.
The Journal of Clinical Investigation|August 16, 2013
Schnurri-3 regulates ERK downstream of WNT signaling in osteoblastsJae-Hyuck Shim, Matthew B Greenblatt, Weiguo Zou, et al.
Experimental & Molecular Medicine|November 18, 2025
PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathwaysJi Hye Shin, Ji Young Kim, Mi-Jeong Kim, et al.
Cell Death & Disease|December 19, 2025
USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesisJi Hye Shin, Ji Young Kim, Seo Hyun Kim, et al.
The Journal of Clinical Investigation|June 17, 2010
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in miceMatthew B Greenblatt, Jae-Hyuck Shim, Weiguo Zou, et al.
Nature|September 26, 2018
Discovery of a periosteal stem cell mediating intramembranous bone formationShawon Debnath, Alisha R Yallowitz, Jason McCormick, et al.
Biomarker Research|July 9, 2025
USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibitionJi Hye Shin, Ji Young Kim, Mi-Jeong Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 10, 2013
Amelioration of neurodegenerative diseases by cell death-induced cytoplasmic delivery of humaninTae-Yoon Park, Seung-Hyung Kim, Yoon-Chul Shin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 2025
New Lens On Congenital Mild Bone Fragility: a Novel Col1a1 Knockout Mouse Model for Osteogenesis Imperfecta Type 1Lidiia Zhytnik, Laura Ventura, Anastasia Sclocco, et al.
The Journal of Experimental Medicine|July 22, 2015
CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclastsMatthew B Greenblatt, Kwang Hwan Park, Hwanhee Oh, et al.
Pageof 9